MTOR and prostate adenocarcinoma: Our results further identify a possible regulatory link between <i>FMR1</i> and key oncogenic pathways, including <i>PI3K_AKT_mTOR</i>, and predict the possible mechanism by which <i>FMR1</i> is regulated in PRAD.